Barr Takes CARE To Monitor Plan B Consumer Behavior Trends
Barr plans to track whether Plan B is being used in lieu of other forms of contraception under its Convenient Access Responsible Education (CARE) postmarketing program
More from Archive
More from Pink Sheet
• By
The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.
• By
An investigation by the US Secretary of Commerce into pharmaceutical imports gives industry an opportunity to comment. AAM CEO John Murphy talked to Pink Sheet's sister publication Scrip about the latest developments.
• By
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include four new products, one of which is Tivdak, Pfizer/Genmab’s treatment for previously treated recurrent or metastatic cervical cancer.